FranceFrance

Bio-people

26.11.2005

Neurotech S.A. (Paris, France) has named Ted Danse as new President and Chief Executive Officer. Danse has a record of more than 25 years in life science industries. He served as President and CEO of the public US ophthalmic pharmaceutical company ISTA Pharmaceuticals Inc. and was Director on the boards of Quest Vision Technologies, Inc. and Vision Solutions Technologies, Inc. Other stations of his carreer include business development roles at Coopervision, Bausch & Lomb, Schering-Plough and Allergan.

FranceFrance

10.07.2010

Paris – This year’s third small IPO went out on the Alternext market of Euronext Paris this year, with molecular diagnostics company IntegraGen S.A. raising EUR6.7m through the sale of 800,149 shares at a8.40, giving it a...

FranceFrance

08.07.2010

Paris – Sanofi-Aventis has secured access to the new drug class of microRNA therapeutics. The company has entered a R&D and marketing collaboration with US firm Regulus Therapeutics Inc., agreeing to pay all R&D and...

FranceFrance

28.06.2010

Strasbourg/Hayworth – Sanofi-Aventis and Metabolix have entered into a global license and development agreement for the development and commercialisation of small molecules that target GPR119, a receptor in the gut and pancreas...

FranceFrance

23.06.2010

Strasbourg/Carlsbad – French pharma giant Sanofi-Aventis has secured access to the new drug class of microRNA therapeutics. The company entered a R&D and markting collaboration with Regulus Therapeutics and will pay all R&D and...

FranceFrance

12.05.2010

Oil-in-water and liposome adjuvants that increase the immune system’s response to the antigen in vaccines have become more common in vaccine formulations in the last decade. They modulate the immune system in different ways than...

FranceFrance

27.04.2010

Paris – French protein kinase inbibitor developer AB Science S.A. has raised EUR16.5 million, through the sale of 1.3 million shares at EUR 12.65 in an IPO on Euronext Paris. Although the company achieved a market capitalisation...

FranceFrance

22.04.2010

Paris/Montpellier – Deinove SA has raised more than €12 million in an IPO on the Alternext market of NYSE Euronext Paris. In total, the specialist for Deinocuccus bacterial manufacture of fine chemicals allocated 1,448,867 shares...

FranceFrance

26.03.2010

Paris - AIDS and cancer specialist BioAlliance Pharma SA has won approval for Setofilm in 16 European countries. Setofilm® is an anti-emetic drug for the prevention and treatment of nausea and vomiting induced by chemotherapy,...

Displaying results 71 to 80 out of 268

< Previous 71-80 Next >

© 2007-2014 BIOCOM

http://www.european-biotechnology-news.com/nc/news/messages-archive/archive-france/browse/7/article/bio-people-2.html

Events

All Events

Stock list

All quotes

TOP

  • NOVACYT (F)4.98 EUR5.96%
  • STALLERGENES (F)53.50 EUR4.37%
  • MORPHOSYS (D)72.25 EUR3.96%

FLOP

  • ANTISOMA (UK)1.32 GBP-14.84%
  • XENETIC BIOSCIENCES (UK)6.00 GBP-14.29%
  • OREXO (S)137.00 SEK-5.35%

TOP

  • WILEX (D)3.10 EUR307.9%
  • SANTHERA (CH)67.95 CHF88.7%
  • ADDEX (CH)4.03 CHF79.9%

FLOP

  • MERCK KGAA (D)64.38 EUR-49.4%
  • HYBRIGENICS (F)1.77 EUR-27.5%
  • CHRONTECH PHARMA (S)0.07 SEK-22.2%

TOP

  • SANTHERA (CH)67.95 CHF3457.6%
  • GW PHARMACEUTICALS (UK)419.75 GBP715.0%
  • PAION (D)2.77 EUR313.4%

FLOP

  • CYTOS (CH)0.26 CHF-92.4%
  • EVOCUTIS (UK)0.21 GBP-91.8%
  • THROMBOGENICS (B)9.54 EUR-69.5%

No liability assumed, Date: 27.07.2014

Job Advert

Executive Director of the IMI Joint Undertaking

The Innovative Medicines Initiative Joint Undertaking (IMI JU) is a public-private partnership between the European Commission and the European Federation of Pharmaceutical Industries Associations (EFPIA).
The Executive Director will lead and manage the Joint Undertaking and take overall responsibility for its operations ensuring the achievement of the Joint Undertaking's objectives. more...


Current issue

All issues

Product of the week

Products